WO2012021409A3 - Anthraquinone Analogs - Google Patents
Anthraquinone Analogs Download PDFInfo
- Publication number
- WO2012021409A3 WO2012021409A3 PCT/US2011/046794 US2011046794W WO2012021409A3 WO 2012021409 A3 WO2012021409 A3 WO 2012021409A3 US 2011046794 W US2011046794 W US 2011046794W WO 2012021409 A3 WO2012021409 A3 WO 2012021409A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- anthraquinone analogs
- anthraquinone
- analogs
- methods
- diones
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/16—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
- C07D249/22—Naphthotriazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Anthraquinone analogs, methods for synthesizing anthraquinone analogs, and methods for inhibiting growth of one or more types of cells using anthraquinone analogs. Anthraquinone analogs can be synsthesized according to methods described herein. Optionally, the synthesis methods described herein include choosing an appropriate leaving group for selectively producing 1-alkyl-1H-naphtho[2,3-d]triazole-4,9-diones or 2-alkyl-2H-naphtho[2,3-d]triazole-4,9-diones. Anthraquinone analogs can include various functional groups that affect their ability to inhibit the growth of various cell types. For example, some anthraquinone analogs disclosed herein have antimicrobial activity while seemingly similar compounds demonstrate anticancer activity but lesser antimicrobial activity.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37253010P | 2010-08-11 | 2010-08-11 | |
US61/372,530 | 2010-08-11 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2012021409A2 WO2012021409A2 (en) | 2012-02-16 |
WO2012021409A3 true WO2012021409A3 (en) | 2012-05-24 |
Family
ID=45568143
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2011/046794 WO2012021409A2 (en) | 2010-08-11 | 2011-08-05 | Anthraquinone Analogs |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2012021409A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103880715B (en) * | 2012-12-19 | 2016-04-06 | 张家港市国泰华荣化工新材料有限公司 | A kind of method of continuous production trifluoromethanesulfonic acid ethyl ester |
CN108467370B (en) * | 2017-11-29 | 2021-11-23 | 四川大学 | Triazole naphthoquinone bi-aromatic ring derivative or triazole naphthoquinone bi-aromatic heterocyclic derivative, and preparation method and application thereof |
CN109293588B (en) * | 2018-11-14 | 2022-02-01 | 四川大学 | Small molecular compound with IDO1/TDO dual-target, and preparation method and application thereof |
CN110218198B (en) * | 2019-05-22 | 2022-06-28 | 广州中医药大学(广州中医药研究院) | Naphthoquinone triazole core skeleton derivative compound and preparation method and application thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0033215A2 (en) * | 1980-01-23 | 1981-08-05 | Beecham Group Plc | Process for preparing anti-allergy naphthotriazoles |
EP0033214A2 (en) * | 1980-01-23 | 1981-08-05 | Beecham Group Plc | Process for preparing therapeutically active triazoles |
-
2011
- 2011-08-05 WO PCT/US2011/046794 patent/WO2012021409A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0033215A2 (en) * | 1980-01-23 | 1981-08-05 | Beecham Group Plc | Process for preparing anti-allergy naphthotriazoles |
EP0033214A2 (en) * | 1980-01-23 | 1981-08-05 | Beecham Group Plc | Process for preparing therapeutically active triazoles |
Non-Patent Citations (3)
Title |
---|
JIANJUN ZHANG ET AL.: "Divergent Synthesis of Three Classes of Aryl N-Glucosides by Solvent Controle", JOURNAL OF ORGANIC CHEMISTRY, vol. 74, no. 2, 2009, pages 685 - 695 * |
JIANJUN ZHANG ET AL.: "Synthesis and antibaceterial activity study of a novel class of cationinc anthraquinone analogs", BIOORGANIC & MEDICINAL CHEMISTRY, vol. 19, no. 11, 2011, pages 498 - 503 * |
SATISH G. BODIGE ET AL.: "2-Amino-1,2,3-triazole derivatives", JOURNAL OF CHEMICAL CRYSTALLOGRAPH, vol. 29, no. 12, 1999, pages 1225 - 1234 * |
Also Published As
Publication number | Publication date |
---|---|
WO2012021409A2 (en) | 2012-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2011107462A3 (en) | Sun protection compositions | |
WO2012135025A3 (en) | Conjugated lipomers and uses thereof | |
MX358682B (en) | Pyrazolo [1, 5a] pyrimidine and thieno [3, 2b] pyrimidine derivatives as irak4 modulators. | |
MY156938A (en) | Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application | |
EP3699176A3 (en) | Antiviral compounds | |
WO2011133876A3 (en) | Oligonucleotides comprising acyclic and abasic nucleosides and analogs | |
NZ631601A (en) | Solid forms of a thiophosphoramidate nucleotide prodrug | |
CA2830549C (en) | Methods and compositions for preparing noribogaine from voacangine | |
MX361413B (en) | Crystalline forms of a macrolide, and uses therefor. | |
WO2014045162A8 (en) | ALKYL-SUBSTITUTED HEXAHYDROPYRANO[3,4-d] [1,3]THIAZIN-2-AMINE COMPOUNDS | |
MX2011008176A (en) | 3, 3' -spiroindolinone derivatives as anticancer agents. | |
WO2008083950A8 (en) | Spirocyclic tetronic acid derivatives | |
CA2873723A1 (en) | Pyrrolopyrimidone and pyrrolopyridone inhibitors of tankyrase | |
WO2012054664A3 (en) | Ink compositions | |
WO2011143772A9 (en) | Inhibitors of hiv replication | |
WO2008140641A3 (en) | Pure paliperidone and processes for preparing thereof | |
WO2011126245A3 (en) | Novel method of preparing vanadosilicate molecular sieve and novel vanadosilicate molecular sieve | |
UA110128C2 (en) | Normal;heading 1;heading 2;heading 3;INDOLECARBOXAMIDES AND BENZIMIDAZOLECARBOXAMIDES AS INSECTICIDES AND ACARICIDES | |
WO2013093931A3 (en) | Novel prodrugs of phenolic drugs | |
WO2013181343A3 (en) | Potted plant systems and methods of making and using the same | |
WO2012021409A3 (en) | Anthraquinone Analogs | |
PL2865664T3 (en) | Novel compound having ability to inhibit 11b-hsd1 enzyme or pharmaceutically acceptable salt thereof, method for producing same, and pharmaceutical composition containing same as active ingredient | |
WO2011085278A3 (en) | Topical scar treatment composition | |
WO2011130317A3 (en) | Therapeutic agents having reduced toxicity | |
MX2010009453A (en) | Topotecan ready to use solutions. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11816863 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 11816863 Country of ref document: EP Kind code of ref document: A2 |